EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

When Digital Biomarkers Drift: A Critical Review of Temporal, Technological, Behavioral, and Population Instability in AI Models for Neurodegenerative Disease

Olaitan Ebenezer Oluwadare, Anyebe Daniel Ameh, Abdul-Basid Yakubu, Faith Uzochi Sunday

Neuroscience Research and Clinical Practice · 16.11.2026 · 2 (2) · 1-24

DOI: 10.64229/8m5kv497 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuroscience Research and Clinical Practice, online erschienen am 16.11.2026. Verfasst von Olaitan Ebenezer Oluwadare und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Digital biomarkers derived from smartphones, wearables, and connected sensors are increasingly combined with artificial intelligence (AI) to detect and monitor neurodegenerative diseases, yet the signals on which these models depend are not static. This critical review, based on a structured search of biomedical, engineering, and regulatory literature, examines four interacting sources of instability: temporal drift arising from disease progression, aging, treatment, and symptom fluctuation; technological drift caused by changes in devices, sensors, software, and processing pipelines; behavioral and contextual drift associated with routines, adherence, engagement, and missing data; and population drift that arises when deployment cohorts differ from narrow development cohorts. We map these sources onto established machine-learning concepts, including covariate shift, label shift, and concept drift, and summarize disease- and modality-specific evidence in Parkinson disease, Alzheimer disease, Huntington disease, and related conditions. Across the literature, separating genuine disease progression from measurement-related, behavioral, and population-related change remains difficult, and validation based on random data splits, short follow-up, homogeneous cohorts, and single devices can overestimate durability. These limitations can produce false deterioration signals, unstable individual predictions, and inequitable performance after deployment. We propose a Detect → Attribute → Quantify → Adapt → Validate → Monitor (DAQAV-M) framework with illustrative operational criteria, attribution strategies, and version-controlled updating rules, and we position it relative to existing dataset-shift, model-monitoring, and regulatory lifecycle approaches. Trustworthy digital biomarkers require lifecycle validation that separates biomarker validity from model performance and tests stability within individuals, across technologies, and across diverse populations.

Zitieren

APA

Oluwadare, O. E., Ameh, A. D., Yakubu, A., & Sunday, F. U. (2026). When Digital Biomarkers Drift: A Critical Review of Temporal, Technological, Behavioral, and Population Instability in AI Models for Neurodegenerative Disease. Neuroscience Research and Clinical Practice, 2(2), 1-24. https://doi.org/10.64229/8m5kv497

Vancouver

Oluwadare OE, Ameh AD, Yakubu A, Sunday FU. When Digital Biomarkers Drift: A Critical Review of Temporal, Technological, Behavioral, and Population Instability in AI Models for Neurodegenerative Disease. Neuroscience Research and Clinical Practice. 2026;2(2):1-24. doi:10.64229/8m5kv497

BibTeX
@article{Oluwadare2026,
  author = {Oluwadare, Olaitan Ebenezer and Ameh, Anyebe Daniel and Yakubu, Abdul-Basid and Sunday, Faith Uzochi},
  title = {When Digital Biomarkers Drift: A Critical Review of Temporal, Technological, Behavioral, and Population Instability in AI Models for Neurodegenerative Disease},
  journal = {Neuroscience Research and Clinical Practice},
  year = {2026},
  volume = {2},
  number = {2},
  pages = {1--24},
  doi = {10.64229/8m5kv497}
}
Kostenlos starten →